youtube_live
Q3 2026 earnings • 8:00 AM tomorrow
See detailschevron_right
HSIC:NASDAQ
Henry Schein Inc
$86.62
arrow_upward
+2.05%(+1.74) 1D
$86.62
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HSIC...
Open
$85.93
High
$87.28
Low
$85.13
Mkt. cap
9.65B
Avg. vol.
1.20M
Volume
2.50M
P/E ratio
25.24
52-wk high
$92.18
52-wk low
$63.04
EPS
$3.43
Beta
0.84
Shares outstanding
111.45M
No. of employees
25K
Open
$85.93
High
$87.28
Low
$85.13
Mkt. cap
9.65B
Avg. vol.
1.20M
Volume
2.50M
P/E ratio
25.24
52-wk high
$92.18
52-wk low
$63.04
EPS
$3.43
Beta
0.84
Shares outstanding
111.45M
No. of employees
25K
News stories
From web sources and news partners
Investing.com
·
10 hours ago
Henry Schein earnings up next as CFO transition looms
Yahoo Finance
·
17 hours ago
Henry Schein (HSIC) reports earnings tomorrow: what to expect
MarketWatch
·
3 days ago
Henry Schein Inc. stock outperforms competitors despite losses on the day
Profile
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners. Wikipedia
About Henry Schein Inc
CEOFrederick Lowery
Employees25K
Founded1932
HeadquartersMelville, New York, United States
SectorHealth care provider
Websitehenryschein.com
Analyst ratings
Based on 16 analysts giving stock ratings to HSIC in the past 3 months
Buy
Buy
9
Hold
6
Sell
1
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for HSIC in the last 3 months.
Highest
Current $86.62
$112.00 (+29.30%)
Average
$98.13 (+13.29%)
Lowest
$64.00 (-26.11%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Michael Petusky Barrington | Buy | Maintained | $104.00 | +20.1% | 10/21/2026 |
Michael Cherny Leerink Partners | Hold | Maintained | $92.00 | +6.2% | 10/14/2026 |
Erin Wright Morgan Stanley | Sell | Reiterated | $64.00 | -26.1% | 10/12/2026 |
Jeff Johnson Robert W. Baird | Buy | Reiterated | $109.00 | +25.8% | 10/09/2026 |
Allen Lutz Bank of America Securities | Buy | Reiterated | $110.00 | +27% | 10/07/2026 |
Jason Bednar Piper Sandler | Buy | Maintained | $104.00 | +20.1% | 09/18/2026 |
David Larsen BTIG | Buy | Maintained | $110.00 | +27% | 08/19/2026 |
John Stansel J.P. Morgan | Buy | Maintained | $102.00 | +17.8% | 08/06/2026 |
Steven Valiquette Mizuho Securities | Hold | Maintained | $86.00 | -0.7% | 08/05/2026 |
Vik Chopra BMO Capital | Hold | Maintained | $85.00 | -1.9% | 08/04/2026 |
Kevin Caliendo UBS | Hold | Maintained | $94.00 | +8.5% | 08/05/2026 |
Jonathan Block Stifel Nicolaus | Hold | Maintained | $95.00 | +9.7% | 08/05/2026 |
Daniel Grosslight Citi | Buy | Maintained | $112.00 | +29.3% | 08/05/2026 |
Glen Santangelo Barclays | Buy | Maintained | $100.00 | +15.4% | 08/05/2026 |
Brandon Vazquez William Blair | Hold | Maintained | - | - | 08/04/2026 |
Elizabeth Anderson CFA Evercore ISI | Buy | Maintained | $105.00 | +21.2% | 08/04/2026 |
Unknown Analyst BMO Capital | Hold | Initiated | $85.00 | -1.9% | 07/09/2026 |
Unknown Analyst Wells Fargo | Hold | Maintained | $87.00 | +0.4% | 02/25/2026 |
Next call in 10:57:28
Tomorrow, 8:00 AM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $1.36
Revenue / Est. (USD)
- / 3.48B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 3.34B | 3.44B | 3.37B | 3.46B |
Cost of goods sold | 2.31B | 2.37B | 2.30B | 2.36B |
Cost of revenue | 2.31B | 2.37B | 2.30B | 2.36B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 753.00M | 812.00M | 806.00M | 832.00M |
Operating expense | 821.00M | 881.00M | 873.00M | 902.00M |
Total operating expenses | 3.13B | 3.26B | 3.17B | 3.26B |
Operating income | 205.00M | 182.00M | 197.00M | 199.00M |
Other non operating income | -1.00M | - | - | 1.00M |
EBT including unusual items | 137.00M | 135.00M | 150.00M | 136.00M |
EBT excluding unusual items | 178.00M | 154.00M | 165.00M | 164.00M |
Income tax expense | 28.00M | 32.00M | 38.00M | 34.00M |
Effective tax rate | 20.44% | 23.70% | 25.33% | 25.00% |
Other operating expenses | - | - | - | - |
Net income | 101.00M | 101.00M | 107.00M | 94.00M |
Net profit margin | 3.02% | 2.94% | 3.18% | 2.72% |
Earnings per share | 1.38 | 1.34 | 1.32 | 1.27 |
Interest and investment income | 9.00M | 9.00M | 7.00M | 8.00M |
Interest expense | -38.00M | -39.00M | -39.00M | -43.00M |
Net interest expenses | -29.00M | -30.00M | -32.00M | -35.00M |
Depreciation and amortization charges | 68.00M | 69.00M | 67.00M | 70.00M |
EBITDA | 285.00M | 234.00M | 278.00M | 283.00M |
Gain or loss from assets sale | - | 30.00M | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events